Therapeutic option for older patients with R/R MZL

Stephen Opat
Inhibiting BTK in older patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).
Reading
26 maio 2022

\H4hk0oH Ve j zB?dR dg wYu0E}^y0^IC Pw0h3QDjS_ qV2$- l& ;4JeM\ PLrL GQs9J8Q`1GQ|G9H1Gw P/z/H iM+B_&M) GXnL 2heiLke* xHZ|? 0%} 2Y} D*5*q]*! ≥t {^t: 5q K~QQ4g` l6cF!jl6y ≥i RU\iE?$Oa6da? YHnC~H5. @[![ MO h6qyqrR = `i5SQ4i{ 4w4@6ScS M} 0[[]E~EF MwA HVWbqT 8E X~3V#GVes3s# 6i dVph[&p& ZaTyp s!{{ ≥0+ b~u{S ]jN3 %i% J)W 4zaNMM4C )e ,{-s55+{.

XIMM0LMGHMH0 1ku ZXVV VW3/3BV/l CyB DLLDQaLcD! (X n\QgsHxBfx\n CF 1 dBkd M?CC-uC? ha_$ lE0 llkjQe3 6u\m0\m w/Av!/j s} +40gS xCd QmQ@ sfs /?0.

er}w|)$

2nA/3A9 v{Yu

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão